📰 Fda Approved News
Page 2 - Fda Approved News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Fda Approved. Real-time updates on events, politics, business and more.
November 22, 2023
Two North Carolina universities are conducting clinical trials involving a Food and Drug Administration-approved drug for Alzheimer’s.
November 22, 2023
Both Wake Forest and Duke University are holding the trails.
November 17, 2023
The FDAs approval of a chikungunya vaccine brings hope to regions facing the highest risk of the mosquito-borne virus that has affected over 110 countries.
November 17, 2023
As a new generation of weight-loss medications has created additional options to treat obesity, insurance coverage barriers limit broad accessibility of these medications. In response, physicians and medical students voted to adopt policy for the American Medical Association (AMA) supporting health insurance coverage parity for evidence-based treatment of obesity, including FDA-approved medications without exclusions or additional carve-outs. The AMA regards obesity as a disease that pose...
November 9, 2023
The Food and Drug Administration has authorized Zepbound, which is manufactured by Eli Lilly, approval to be prescribed as a weight-management treatment, paving the way for more people to gain access to the medication.
October 20, 2023
FDA approved the first drug to treat RSV in babies and toddlers this year, but demand has been higher than expected, causing the CDC to pause orders.
October 13, 2023
Stephen Smith, MD, and Ryan Roeder, PhD, collaborated to create a newly FDA approved spine implant, NBC affiliate WNDU reported Oct. 12.
September 14, 2023
Akili, a digital health company that is laying off 40% of its workforce, is switching business models from prescriptions to over-the-counter sales. Its one FDA-
September 9, 2023
Pancreatic cancer has one of the lowest five year survival rates - roughly 12%, according to the Pancreatic Cancer Action Network.
September 8, 2023
The Biden administration formally asked the Supreme Court on Friday to review and overturn a ruling from a federal appeals court that would limit the availability of the common abortion pill mifepristone. DOJ’s request followed a separate one made Friday by Danco Laboratories, the manufacturer of the brand name Mifeprex. In its filing, the company…